Zintrexyl-C is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Puretek Corporation. The primary component is Vitamin A Acetate; Ascorbic Acid; Cholecalciferol; .alpha.-tocopherol Acetate, Dl-; Thiamine Mononitrate; Riboflavin; Niacinamide; Pyridoxine Hydrochloride; Folic Acid; Cyanocobalamin; Biotin; Pantothenic Acid; Calcium Carbonate; Ferrous Fumarate; Potassium Iodide; Magnesium Oxide; Zinc Oxide; Selenium; Cuprous Oxide; Manganese Sulfate; Chromium Nicotinate; Molybdenum; Potassium Chloride; Boron.
| Product ID | 59088-180_bb1492c5-bfca-d632-e053-2a95a90ad7d1 |
| NDC | 59088-180 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Zintrexyl-C |
| Generic Name | Ferrous Fumarate, Folic Acid |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-02-11 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | PureTek Corporation |
| Substance Name | VITAMIN A ACETATE; ASCORBIC ACID; CHOLECALCIFEROL; .ALPHA.-TOCOPHEROL ACETATE, DL-; THIAMINE MONONITRATE; RIBOFLAVIN; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; FOLIC ACID; CYANOCOBALAMIN; BIOTIN; PANTOTHENIC ACID; CALCIUM CARBONATE; FERROUS FUMARATE; POTASSIUM IODIDE; MAGNESIUM OXIDE; ZINC OXIDE; SELENIUM; CUPROUS OXIDE; MANGANESE SULFATE; CHROMIUM NICOTINATE; MOLYBDENUM; POTASSIUM CHLORIDE; BORON |
| Active Ingredient Strength | 1500 ug/1; mg/1; ug/1; mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1; ug/1; mg/1; mg/1; ug/1; ug/1; mg/1; ug/1 |
| Pharm Classes | Vitamin A [CS],Vitamin A [EPC],Vitamin C [EPC],Ascorbic Acid [CS],Vitamin D [CS],Vitamin D [EPC],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient],Vitamin B 12 [CS],Vitamin B12 [EPC],Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Calcium [CS],Cations, Divalent [CS],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Copper Absorption Inhibitor [EPC],Decreased Copper Ion Absorption [PE],Magnetic Resonance Contrast Activity [MoA],Paramagnetic Contrast Agent [EPC],Nicotinic Acid [EPC],Nicotinic Acids [CS],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2021-02-11 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 59088-180 | Zintrexyl-C | Ferrous Fumarate, Folic Acid |
| 59088-480 | Foliflex | Ferrous Fumarate, Folic Acid |
| 59088-181 | Folitin-Z | Ferrous Fumarate, Folic Acid |
| 59088-166 | Prenatrix | Ferrous Fumarate, Folic Acid |
| 59088-169 | Prenatryl | Ferrous Fumarate, Folic Acid |
| 59088-178 | Pretrate | Ferrous Fumarate, Folic Acid |
| 59088-172 | Prometa | Ferrous Fumarate, Folic Acid |
| 59088-182 | Ribotin-E | Ferrous Fumarate, Folic Acid |
| 59088-177 | Venexa FE | Ferrous Fumarate, Folic Acid |
| 59088-187 | Ventrixyl Fe | Ferrous Fumarate, Folic Acid |
| 59088-173 | Vitranol Fe | Ferrous Fumarate, Folic Acid |
| 59088-168 | Vitrexate FE | Ferrous Fumarate, Folic Acid |
| 59088-165 | Vitrexyl plus Iron | Ferrous Fumarate, Folic Acid |